心肌缺血再灌注损伤的发生机制及其防治策略(5)
[23] Yu H，Shi L，Qi G，et al. Gypenoside protects cardiomyocytes against ischemia-reperfusion injury via the inhibition of mitogen-activated protein kinase mediated nuclear factor kappa B pathway in vitro and in vivo [J]. Front Pharmacol ......
您现在查看是摘要页，全文长 2128 字符。